Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
- 1 January 2005
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 365 (9457), 434-441
- https://doi.org/10.1016/s0140-6736(05)17833-7
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugsClinical Medicine, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugsThe Lancet, 2002
- Blood Pressure and Coronary Heart Disease: A Review of the EvidenceSeminars in Vascular Medicine, 2002
- Optimal age for starting lipid lowering treatmentBMJ, 2000
- Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey populationBMJ, 2000
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Some lessons in cardiovascular epidemiology from FraminghamThe American Journal of Cardiology, 1976